1.
Reich K, Lebwohl M, Paul C, Ropke M, Rosen M, Hansen K. Brodalumab, a Human Anti-Interleukin-17 Receptor A Monoclonal Antibody, Shows Low Immunogenicity in Patients with Moderate-to-Severe Psoriasis. J of Skin [Internet]. 2018Feb.23 [cited 2024Sep.20];2(S1):S1. Available from: https://dermsquared.com/skin/article/view/254